Barbet C - Search Results

1

Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.

Maisons V, Duval A, Mesnard L, Frimat M, Fakhouri F, Grangé S, Servais A, Cartery C, Fauchier L, Coppo P, Titeca-Beauport D, Fage N, Delmas Y, Quérard AH, Seret G, Bobot M, Le Quintrec M, Ville S, von Tokarski F, Chauvet S, Wynckel A, Martins M, Schurder J, Barbet C, Sautenet B, Gatault P, Caillard S, Vuiblet V, Halimi JM; MATRIX Consortium Group. Maisons V, et al. Among authors: barbet c. Kidney Int. 2024 May;105(5):1100-1112. doi: 10.1016/j.kint.2024.02.014. Epub 2024 Feb 29. Kidney Int. 2024. PMID: 38431217

2

Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.

Roland M, Gatault P, Doute C, Büchler M, Al-Najjar A, Barbet C, Chatelet V, Marlière JF, Nivet H, Lebranchu Y, Halimi JM. Roland M, et al. Among authors: barbet c. Transpl Int. 2008 Jun;21(6):523-30. doi: 10.1111/j.1432-2277.2008.00640.x. Epub 2008 Feb 4. Transpl Int. 2008. PMID: 18266773 Free article.

3

Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.

Roland M, Barbet C, Paintaud G, Magdelaine-Beuzelin C, Diot E, Halimi JM, Lebranchu Y, Nivet H, Büchler M. Roland M, et al. Among authors: barbet c. Lupus. 2009 Apr;18(5):441-7. doi: 10.1177/0961203308098631. Lupus. 2009. PMID: 19318398

4

Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation.

Gatault P, Jollet I, Rabot N, Boulanger MD, Taupin JL, Barbet C, Baron C, Thierry A, Halimi JM, Lebranchu Y, Touchard G, Büchler M. Gatault P, et al. Among authors: barbet c. Tissue Antigens. 2011 Oct;78(4):241-8. doi: 10.1111/j.1399-0039.2011.01757.x. Tissue Antigens. 2011. PMID: 21929572

5

Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantation.

Gatault P, Al-Najjar A, Barbet C, Roland M, Laouad I, Buchler M, Marlière JF, Métais PE, Clément A, Nivet H, Lebranchu Y, Halimi JM. Gatault P, et al. Among authors: barbet c. Transplantation. 2011 Nov 15;92(9):1012-7. doi: 10.1097/TP.0b013e31823015e4. Transplantation. 2011. PMID: 21941225

6

Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation.

Mutinelli-Szymanski P, Caille A, Tranquart F, Al-Najjar A, Büchler M, Barbet C, Marlière JF, Gatault P, Réault J, Boin C, Chatelet V, Laouad I, Nivet H, Lebranchu Y, Halimi JM. Mutinelli-Szymanski P, et al. Among authors: barbet c. Transpl Int. 2012 Apr;25(4):464-70. doi: 10.1111/j.1432-2277.2012.01445.x. Epub 2012 Feb 24. Transpl Int. 2012. PMID: 22364312 Free article.

7

New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients.

Benz-de Bretagne I, Le Guellec C, Halimi JM, Gatault P, Barbet C, Alnajjar A, Büchler M, Lebranchu Y, Andres CR, Vourcʼh P, Blasco H. Benz-de Bretagne I, et al. Among authors: barbet c. Ther Drug Monit. 2012 Jun;34(3):289-97. doi: 10.1097/FTD.0b013e31824a6534. Ther Drug Monit. 2012. PMID: 22585184 Clinical Trial.

8

Renal function of renal transplantation patients after hospitalization in an intensive care unit.

Badin J, Longuet H, Guillon A, Barbet C, Halimi JM, Lebranchu Y, Perrotin D, Buchler M. Badin J, et al. Among authors: barbet c. Transplant Proc. 2012 Nov;44(9):2792-4. doi: 10.1016/j.transproceed.2012.09.027. Transplant Proc. 2012. PMID: 23146526

9

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V. Fakhouri F, et al. Among authors: barbet c. Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8. Am J Kidney Dis. 2014. PMID: 24021908

10

Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.

Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, Büchler M. Longuet H, et al. Among authors: barbet c. Transpl Int. 2014 Mar;27(3):271-9. doi: 10.1111/tri.12249. Epub 2013 Dec 27. Transpl Int. 2014. PMID: 24279588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page